SMTI | Sanara MedTechNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$32.17
+$0.10 (+0.31%)

Sanara MedTech (SMTI) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.

The 50 SMA has sat above the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is above both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $32.17 vs 50 $34.42 / 200 $25.57
Projection
No cross projected
Test
No active test
Last cross
Golden cross 20 Jul 2026 ยท projected 21 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $32.83 vs 50 $25.02 / 200 $32.06
Projection
Golden cross estimated 15+ weeks out
Test
No active test
Last cross
Death cross week of 27 Jan 2025 ยท projected 11 bars out ยท tested 4 bars

Cross history

28
crosses on record since 2021
14 golden14 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
20 Jul 2026Golden moderatedaily21 bars outNot tested
26 May 2026Golden4-hour24 bars outโ€”
14 Nov 2025Death moderatedaily19 bars outNot tested
6 Nov 2025Death4-hour22 bars outNot tested
10 Oct 2025Golden moderatedaily28 bars out3 bar cross test

About SMTI

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$6.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.